Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
New York, NY, USA
Attenuated Gastric Ulcers, Seizures, Brain Lesions, Hepatomegaly, Fatty Liver, Breakdown of Liver Glycogen, Profound Hypoglycemia and Calcification in Rats
Batch number RGXBPC15710-2602-01 was tested and confirmed as follows: Purity: 99.1% (HPLC peptide screening) Identity by retention time: Confirmed (score: 0.999) Identity by mass spectrum: Confirmed (score: 993) Assay content: 14.64 mg per vial Endotoxins: /Eur
Mallampalli, PhD Key Takeaways: Compounded or counterfeit tirzepatide is not verified for safety, effectiveness, or quality, increasing the risk to patients since it is not FDA-approved
Description Overview AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone and is widely referenced in research on adipose tissue metabolism, lipolysis and body-composition management models
US$ 21.43
US$ 21.85
US$ 23.63
US$ 27.10
US$ 23.48
